This is our last issue of this year, and what a year it has been in the diabetes world in general and in the UK
BHR markets and supports the use of their point of care diagnostic products for use in GP surgeries, hospitals and other locations, and is now
Among the news items in this issue is one about the need to move away from the relatively well-known concept of your BMI (body mass
According to an article in DiaTribe, researchers have suggested that the new drugs developed to help people with Type 2 diabetes to lose weight, lower
With the World Health Organisation (WHO) reporting that overweight and obesity has reached “epidemic proportions” in Europe, causing more than an estimated 1.2 million deaths every
Waist-to-hip ratio (WHR) is a stronger predictor of early death than body mass index (BMI) and should be considered as a superior measure of healthy
JDRF have announced a ‘Type 1 Diabetes Discovery Event & Technology Exhibition in Redmaids’ High School, Bristol between 10:00–5:30 on 29 October 2022. Held in
Our September issue is packed full of news. Some about medications, some about vitamins (well, vitamin D in particular) as well as device updates. Insulin
Although things do tend to be a little quieter over the summer months, the fact is that this is another issue filled-to-busting with news and
Vertex to acquire ViaCyte, with the goal of accelerating its potentially curative VX-880 programmes in Type 1 diabetes. ViaCyte brings tools, technologies and assets with
